Table 1.
Baseline characteristics comparison between Cohort 1 and Cohort 2 (overall ITT group)
| Characteristic | Cohort 1 N = 115 |
Cohort 2 (ITT) N = 136 |
P value |
|---|---|---|---|
| Age, (years) mean ± SD | 67 ± 7.6 | 66 ± 8.5 | NS |
| Male gender, N (%) | 82 (71%) | 95 (70%) | NS |
| Weight, (kg) mean ± SD | 86.5 ± 18.6 | 89.5 ± 22.0 | NS |
| BMI, (kg/m2) mean ± SD | 30.0 ± 6 | 30.7 ± 6.6 | NS |
| Diabetes type, N (%) | |||
| - Type 1 | 9 (7.8%) | 10 (7.4%) | NS |
| - Type 2 | 98 (85.2%) | 120 (88.2%) | NS |
| - Unknown | 8 (7.0%) | 6 (4.4%) | NS |
| Diabetes therapy, N (%) | |||
| - Insulin | 60 (52.2%) | 63 (46.3%) | NS |
| - Oral therapy | 87 (75.6%) | 108 (79.4%) | NS |
| BGL, (mmol/L) | |||
| - Mean ± SD | 14.5 ± 2.6 | 14.4 ± 2.6 | NS |
| - Range | 10.5–22.7 | 10.4–24.3 | |
ITT intention to treat, SD standard deviation, N number, BMI body mass index, BGL blood glucose level, NS not significant (P > 0.05)